Diuretics Drugs Market, By Drug Class (Thiazide Diuretics (e.g., hydrochlorothiazide, chlorthalidone, indapamide, metolazone), Loop Diuretics (e.g., furosemide, bumetanide, ethacrynic acid, torsemide), Potassium-Sparing Diuretics (e.g., spironolactone, amiloride, triamterene, eplerenone), Carbonic Anhydrase Inhibitors (e.g., acetazolamide, methazolamide), Osmotic Diuretics (e.g., mannitol), and Other Combination Products), By Indication (Hypertension, Glaucoma, Edema (e.g., Heart Failure, Renal Impairment, Cirrhosis) , Idiopathic Intracranial Hypertension, Altitude Sickness, and Hyperaldosteronism), By Route of Administration (Oral and Parenteral), By Mechanism of Action (Sodium-Chloride Cotransporter Inhibitors, Sodium-Potassium-Chloride Cotransporter Inhibitors, Aldosterone Antagonists, Carbonic Anhydrase Blockers, Osmotic Pressure Regulators), By Age Group (Pediatric, Adult, and Geriatric), By Formulation Type (Tablets/Capsules, Oral Solutions, and Injections), By Type (Branded and Generic), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By End User (Hospitals, Specialty Clinics, Homecare Settings, and Research and Academic Institutes), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Growth Trends and Forecasts (2025-2032)